Steven Lin, MD, PhD

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    STCube Pharmaceuticals
    Topic: 
    Immunomodulators
    Date added: 
    11/10/2022
    Relationship end date: 
    12/31/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Beyond Spring Pharmaceuticals
    Topic: 
    Immunomodulators
    Date added: 
    11/10/2022
    Relationship end date: 
    03/31/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Nektar Therapeutics
    Topic: 
    Immunomodulators
    Date added: 
    11/10/2022
    Relationship end date: 
    07/31/2025
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    XRAD Therapeutics
    Topic: 
    Radiation Sensitizers
    Date added: 
    11/10/2022
    Relationship end date: 
    12/31/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    AstraZeneca
    Topic: 
    Immunomodulators
    Date added: 
    11/10/2022
    Relationship end date: 
    12/31/2022
Return to San Diego Multidisciplinary Thoracic Oncology Symposium: Patient-centered approach to improve outcomes